PROMOTION
VISCODERM 2% maxx Natural HA for facial volume and skin tone
Alessandro Gennai and Luigi Izzo discuss the use of a pure, natural hyaluronic acid for full facial rejuvenation, while also enhancing volume and overall skin tone.
F
DR. ALESSANDRO GENNAI and DR. LUIGI IZZO are Aesthetic Plastic Surgeons with a private practice in Bologna, Italy, focusing on facial rejuvenation by Aesthetic Medicine and surgery. They are members of Italian Society of Plastic Reconstructive and Aesthetic Surgery.
Contact information:
info@gennaichirurgia.it
tissues glide downward.
ACIAL AGEING RESULTS in volume loss as a result of subcutaneous fat and bone reabsorption. Structural support fails and In
addition, skin ageing is accelerated by sun exposure, cigarette smoking and other lifestyle habits, all of which negatively affect the skin, resulting in aged skin with lost hydration, tone, and elasticity, and leading to wrinkle formation and opaque skin. Therefore, restoring lost facial
volume and skin hydration become our main goals in facial rejuvenation. The authors use hyaluronic acid (HA), a physiological macromolecule of the dermis, which presents a high capacity of binding water molecules, simultaneously improving volume and water content of the tissues. It is degraded by the action of the hyaluronidase enzymes, over a variable period of time, depending on genetics, lifestyle and other factors.
Preferences and techniques The preferred HA of the authors is of a ‘pure’ rather than cross-linked formulation: 20 mg/ml in a buffered
saline solution. Viscoderm® MAXX (IBSA Farmaceutici Italia) offers this formulation in a 2.5 ml sterile pre-filled syringe to supply the physician with enough volume to treat extended areas of the face. We strongly believe that this formulation has the advantage of a higher water binding capacity, restoring skin hydration, and is able to stimulate fibroblast activity, enhancing the production of collagen.
allo“Pure hyaluronic acid ” ws the physician to
inject greater amounts, without incurring any adverse effects.
Furthermore, pure HA allows the
physician to inject greater amounts, without incurring any adverse effects (most notably, swelling). The absence of swelling and other significant adverse reactions allows us to inject HA in every facial region (Figure 1), without fear of patient complaints or unnatural outcomes. On the other hand, however, cross-linking acts as a shield against hyaluronidase enzymes, so injecting pure HA results a lesser survival duration than cross-linked HAs. The technique and injection depth
72 ❚
varies according to the areas to be treated. A 27 G fine needle 19 mm long is our most frequent choice — it allows us to reach any tissue depth and to reduce the force needed to inject the HA. In some cases we
March 2012 |
prime-journal.com
prefer injecting using a 27 G blunt cannula 40 mm long, in order to maximise the surface area of HA injected in the tissues, especially in thinner areas.
Conclusions A young face is a full face with light skin, whereas an aged face shows flattened facial contours and a flaccid, opaque skin. Volume restoration creates the convexities and fullness of a young face. Fibroblast stimulation and therefore collagen production (the biorestructuring effect of HA), improves skin tone, enchances hydration and reduces wrinkles, giving a younger appearance to the skin.
HA is a safe, non-invasive and
fast method to sculpt facial contours, and pure HA hydrates tissues and contributes to a more even skin tone. HA gives an excellent structural support and acts as a stimulus for fibroblasts to re-structure the skin by enhancing collagen deposition. The 2.5 ml Viscoderm® MAXX formulation provides the physician with all the volume needed to simultaneously improve facial contours and skin tone.
References
1. Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg 2007; 19(7): 2219–27
2. Shaw RB Jr, Katzel EB, Koltz PF et al. Aging of the facial skeleton: aesthetic implications and rejuvenation strategies. Plast Reconstr Surg 2011; 127(1): 374–83
3. Gennai A. Endochirurgia Estetica del Volto. Florence: SEE, 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112